Zobrazeno 1 - 10
of 49
pro vyhledávání: '"I N SUBORTSEVA"'
Autor:
A L Melikyan, I N Subortseva, E A Koloshejnova, E A Gilyazitdinova, K S Shashkina, L A Gorgidze, Zh V Tratsevskaya, O V Margolin
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 93-99 (2019)
Thrombosis is a serious and extremely dangerous disease that has a negative impact on the quality and longevity. Antiphospholipid syndrome (APS) is a pathology characterized by recurring venous, arterial, microvasculature thrombosis, pregnancy pathol
Externí odkaz:
https://doaj.org/article/03566734257242a49562c756e74fd66b
Autor:
A L MELIKYAN, I N SUBORTSEVA, E A GILYAZITDINOVA, T I KOLOSHEJNOVA, E I PUSTOVAYA, E K EGOROVA, A M KOVRIGINA, A B SUDARIKOV, A O ABDULLAEV, E G LOMAIA, N T SIORDIYA, A Yu ZARITSKEY, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 23-29 (2018)
Purpose of the study. A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Materials and methods. Patients with PV or ET, diagnosed according to
Externí odkaz:
https://doaj.org/article/24b0a0e7af394e34811b114da05d6bfc
Autor:
A L Melikyan, I N Subortseva, A B Sudarikov, A M Kovrigina, E A Gilyazitdinova, T I Kolosheinova, A O Abdullaev, S A Treglazova
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 4-9 (2017)
The aim of the present paper was to evaluate the clinical features and risk of thrombotic events (TE) in patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF), depending on the molecular characteristics of disease. Clinical dat
Externí odkaz:
https://doaj.org/article/fff1484298094c0d95e324ea2cf2b148
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 102-104 (2018)
This article describes several clinical cases of acute ischemic stroke among patients suffering from essential thrombocytemia. Ambiguity of etiological factors of stroke is demonstrated among patients with this pathology. Thrombocytosis and high alle
Externí odkaz:
https://doaj.org/article/e904a28fb7a14817815d927773c31109
Autor:
A L Melikian, I N Subortseva, A M Kovrigina, T I Kolosheynova, A O Abdullaev, P I Kuznetsova, A B Sudarikov, S M Kulikov
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 25-30 (2016)
Aim. To identify the clinical features of latent polycythemia vera (PV) as an independent nosological entity. Subjects and methods. The investigation enrolled 81 patients (50 with extensive (manifest) PV and 31 with latent PV) who had visited the Out
Externí odkaz:
https://doaj.org/article/95aa383eba41407ba5220412f833277f
Publikováno v:
Терапевтический архив, Vol 88, Iss 1, Pp 89-95 (2016)
Patients with myeloproliferative diseases (MPD) are noted to be at high risk for portal thromboses. This problem gives rise to disability if it is untimely treated or resistant to therapy. The paper gives the experience of the Outpatient Department o
Externí odkaz:
https://doaj.org/article/c39a8eeb2d024e029564869ef450ef47
Autor:
A L Melikyan, E K Egorova, А М Kovrigina, I N Subortseva, E A Gilyazitdinova, S R Karagyulyan, M A Silaev, E G Gemdzhian, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 64-71 (2015)
Aim. To study the clinical features of Castleman’s disease (CD) and to elaborate therapeutic approaches in its different morphological types. Subjects and methods. The clinical and laboratory data were studied in 59 prospectively examined patients
Externí odkaz:
https://doaj.org/article/2f541c08aee04f028aa9979b94beedf5
Autor:
A L Melikian, I N Subortseva, S R Goriacheva, T I Kolosheĭnova, M V Vakhrusheva, A M Kovrigina, A B Sudarikov, V N Dvirnyk, T N Obukhova
Publikováno v:
Терапевтический архив, Vol 86, Iss 12, Pp 127-134 (2014)
The term mastocytosis (MC) encompasses a group of rare diseases characterized by the tumorous proliferation of clonal mast cells and the infiltration of one or several organs. The clinical picture of MC is extremely diverse from skin lesions that can
Externí odkaz:
https://doaj.org/article/e5078b08a1ec468b92897ee4ac3af83d
Autor:
A L Melikian, T I Kolosheĭnova, S R Goriacheva, I N Subortseva, M V Vakhrusheva, E N Kolosova, A B Sudarikov, A O Abdullaev, V N Dvirnyk, E Iu Varlamova, A M Kovrigina, A G Turkina
Publikováno v:
Терапевтический архив, Vol 86, Iss 7, Pp 37-44 (2014)
AIM. To determine the clinical features of multiple primary tumors (MPT) in patients with hemoblastoses, to develop treatment policy for synchronous and metachronous tumors, and to determine the impact of chemotherapy for one disease on the course an
Externí odkaz:
https://doaj.org/article/5f12c74511724a4182f454278733a615
Publikováno v:
Современная онкология, Vol 14, Iss 3, Pp 50-56 (2012)
Externí odkaz:
https://doaj.org/article/f7b775bc0f1843fea00509802368a891